☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Selexis Signs a Service Agreement with NexImmune to Advance Multiple Immunotherapies for Rare Cancers and Autoimmune Disorders
September 8, 2022
Top 20 Oncology Companies Based on 2021 Oncology Segment Total Revenue
September 8, 2022
Brainomix Collaborated with Bridge Biotherapeutics for BBT-877 to Treat Idiopathic Pulmonary Fibrosis Using AI-Powered e-ILD Softw...
September 8, 2022
HUTCHMED Presents P-III (FRESCO-2) MRCT Study Results of Fruquintinib for Refractory Metastatic Colorectal Cancer at ESMO 2022
September 8, 2022
UCB Presents New Three-Year P-III (BE BRIGHT) OLE Study Results of Bimekizumab for Plaque Psoriasis at EADV 2022
September 8, 2022
Innovent Reports Second Interim P-III (ORIENT-31) Study Results of Tyvyt (sintilimab) + Byvasda (biosimilar, bevacizumab) for EGFR...
September 8, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions